Indee

09/09/2024

Check out our latest blog post on how Hydropore improve sequential multiplex editing yields!

From previous work, we have shown the efficacy of hydroporation in the generation of functional CAR+ T-cells, with higher yields and similar functionality to those generated by conventional electroporation. Here, we show that hydroporation can be used to generate universal CAR+T cells through multip

27/06/2024

Check out our latest pre-print on how Hydropore enhances CAR-T function with Justin Eyquem at UCSF and Leonardo Ferreira at Medical University of South Carolina (MUSC)! https://hubs.li/Q02DBzxG0

06/11/2023

Hydropore enhances CAR-T cell function in vitro. Want to learn more? Check out our latest blog post!

Recent studies suggest a strong connection between CAR-T proliferation, how long they last inside the patient’s body, and how well the patient responds to the treatment [3,16]. To better understand the connection, scientists have examined the ability of CAR-T cells to activate the appropriate immu...

23/12/2022

Happy Holidays from Indee!

01/12/2022

Indee Labs Partners With Monomer Bio to Automate Engineered Immune Cell Culture! Indee

https://hubs.li/Q01tHKH70

Indee Labs partners with Monomer Bio to automate Hydropore workflows for engineered T cells and similar immune cell types.

17/11/2022

Are you attending in person or virtually? Schedule a meeting with the team to learn more our efforts on Hydropore for Research Use Only and Cell Therapy!

https://hubs.li/Q01svSB00

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.

02/11/2022

Indee Labs Awarded $2M Contract to Scale up and out Hydropore for Cell Therapy

https://hubs.ly/Q01rfVkM0

Indee Labs announces a $2M contract with the National Cancer Institute to scale up and out the Hydropore platform for cell therapy with Eyquem Lab at UCSF.

22/08/2022

https://web.musc.edu/about/news-center/2022/08/22/musc-immunology-researcher-receives-sbir-grant-to-push-boundaries-of-regulatory-tcell-therapy

An MUSC Hollings Cancer Center researcher is among the first to use a new device meant to improve Treg gene editing.

08/06/2021

We are excited to introduce Hydropore™ for cell biology and cell therapy research, now available for Research Use Only! Check out our latest blog post to learn more!

https://hubs.li/H0PT7W20

Hydropore™ is a novel, non-viral delivery platform now available for Research Use Only (RUO). Hydropore™ offers researchers a reliable alternative to electroporation, and can rapidly and efficiently introduce nucleic acids, proteins and gene-editing complexes into cells for a variety of applicat...

08/06/2021

We are excited to introduce Hydropore™ for cell biology and cell therapy research, now available for Research Use Only! Check out our latest blog post to learn more!

https://hubs.li/H0PSVWC0

Hydropore™ is a novel, non-viral delivery platform now available for Research Use Only (RUO). Hydropore™ offers researchers a reliable alternative to electroporation, and can rapidly and efficiently introduce nucleic acids, proteins and gene-editing complexes into cells for a variety of applicat...

08/02/2021

Check out our updated bioRxiv pre-print on CRISPR-Cas9 genome editing with µVS! Let us know what you think and be sure to explore our new website.

https://hubs.li/H0Gf9M00

Microfluidic vortex shedding ( μVS ) can rapidly deliver mRNA to T cells with high yield. The mechanistic underpinning of μVS intracellular delivery remains undefined and μVS -Cas9 genome editing requires further studies. Herein, we evaluated a series of μVS devices containing splitter plates to...

05/01/2021

Indee Labs Announces Successful Early Access Program Launch

https://hubs.li/H0DjtBK0